Search
Search Constraints
You searched for: Journal Cancer letters Issue Volume 380:Issue 2(2016)Limit your search
- 616.994 33
- Cancer -- Periodicals 33
- Cancer -- Périodiques 33
- Electronic journals 33
- Neoplasms -- Periodicals 33
- 2D two dimensional -- 2D DIGE two dimensional difference gel electrophoresis -- 3′ UTR 3′ untranslated region -- 3D three dimensional -- ADH atypical ductal hyperplasia -- ANXA2 annexin A2 -- ANXA8 annexin A8 -- C.I. confidence interval -- DCIS ductal carcinoma in situ -- ERA estrogen receptor alpha -- EV empty vector -- HME1 human mammary epithelial cell line -- HME1-MYC HME1 cells overexpressing MYC -- HME1-shERA ERA knock down HME1 cells -- HME1-shMTG16 MTG16 knock down HME1 cells -- HME1-shPER2 PER2 knock down HME1 cells -- HME1-shANXA2 ANXA2 knock down cells -- IPA ingenuity pathway analysis -- miRNA microRNA -- MW molecular weight -- PI isoelectric point -- PER2 Period 2 -- RA retinoic acid -- RARA403 dominant negative RA receptor alpha -- SCR scrambled -- TMA tissue microarray 1
- 3D mammary epithelial morphogenesis -- Breast cancer -- Ductal carcinoma in situ (DCIS) -- Biomarkers -- Annexins 1
- ADMET absorption, distribution, metabolism, excretion, toxicity -- PK pharmacokinetic -- CDK cyclin-dependent kinase -- PKA protein kinase A -- Akt protein kinase B -- PKC protein kinase C -- GLP good laboratory practice -- IND investigational new drug 1
- Anaplastic thyroid cancer -- Cachexia -- Cytokines -- Angiogenesis -- Inflammation -- BRAFV600E 1
- Ang-2 targeting -- Angiogenesis -- Anti-angiogenic therapy -- VEGF targeting -- Combination therapy 1